APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Traveler's Diarrhea

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drugs for Traveler's Diarrhea Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchDrugs for Traveler's Diarrhea Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Traveler's Diarrhea Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Drugs for Traveler's Diarrhea Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Traveler's Diarrhea Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Traveler's Diarrhea Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Drugs for Traveler's Diarrhea market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drugs for Traveler's Diarrhea is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs for Traveler's Diarrhea is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs for Traveler's Diarrhea is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drugs for Traveler's Diarrhea market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drugs for Traveler's Diarrhea market include GSK, Sigmoid Pharma, Scandinavian Biopharma, Salix Pharmaceuticals, Prokarium Limited, Nippon Shinyaku, Cosmo Pharmaceuticals and Chiesi Farmaceutici, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drugs for Traveler's Diarrhea market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs for Traveler's Diarrhea and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs for Traveler's Diarrhea sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drugs for Traveler's Diarrhea market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs for Traveler's Diarrhea Segment by Company

GSK

Sigmoid Pharma

Scandinavian Biopharma

Salix Pharmaceuticals

Prokarium Limited

Nippon Shinyaku

Cosmo Pharmaceuticals

Chiesi Farmaceutici

Drugs for Traveler's Diarrhea Segment by Type

Antibiotics

Anti-motility agents

Bismuth Subsalicylate (Pepto-Bismol)

Drugs for Traveler's Diarrhea Segment by Application

Adult

Children

Drugs for Traveler's Diarrhea Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drugs for Traveler's Diarrhea status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Drugs for Traveler's Diarrhea market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drugs for Traveler's Diarrhea significant trends, drivers, influence factors in global and regions.

6. To analyze Drugs for Traveler's Diarrhea competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Traveler's Diarrhea market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Traveler's Diarrhea and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Traveler's Diarrhea.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drugs for Traveler's Diarrhea market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Traveler's Diarrhea industry.

Chapter 3: Detailed analysis of Drugs for Traveler's Diarrhea manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Drugs for Traveler's Diarrhea in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Drugs for Traveler's Diarrhea in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drugs for Traveler's Diarrhea Industry Trends Table 2. Drugs for Traveler's Diarrhea Industry Drivers Table 3. Drugs for Traveler's Diarrhea Industry Opportunities and Challenges Table 4. Drugs for Traveler's Diarrhea Industry Restraints Table 5. Global Drugs for Traveler's Diarrhea Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drugs for Traveler's Diarrhea Revenue Share by Company (2021-2026) Table 7. Global Drugs for Traveler's Diarrhea Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Drugs for Traveler's Diarrhea Sales Volume Share by Company (2021-2026) Table 9. Global Drugs for Traveler's Diarrhea Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Drugs for Traveler's Diarrhea Company Ranking, (2024-2026) & (USD Million) Table 11. Global Drugs for Traveler's Diarrhea Key Company Manufacturing Base & Headquarters Table 12. Global Drugs for Traveler's Diarrhea Company, Product Type & Application Table 13. Global Drugs for Traveler's Diarrhea Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Drugs for Traveler's Diarrhea by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antibiotics Table 18. Significant Companies of Anti-motility agents Table 19. Significant Companies of Bismuth Subsalicylate (Pepto-Bismol) Table 20. Global Drugs for Traveler's Diarrhea Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Drugs for Traveler's Diarrhea Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Drugs for Traveler's Diarrhea Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Drugs for Traveler's Diarrhea Sales Volume Share by Type (2021-2026) Table 24. Global Drugs for Traveler's Diarrhea Sales Volume Share by Type (2027-2032) Table 25. Global Drugs for Traveler's Diarrhea Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drugs for Traveler's Diarrhea Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Drugs for Traveler's Diarrhea Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Drugs for Traveler's Diarrhea Sales Value Share by Type (2021-2026) Table 29. Global Drugs for Traveler's Diarrhea Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Adult Table 31. Significant Companies of Children Table 32. Global Drugs for Traveler's Diarrhea Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Drugs for Traveler's Diarrhea Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Drugs for Traveler's Diarrhea Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Drugs for Traveler's Diarrhea Sales Volume Share by Application (2021-2026) Table 36. Global Drugs for Traveler's Diarrhea Sales Volume Share by Application (2027-2032) Table 37. Global Drugs for Traveler's Diarrhea Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Drugs for Traveler's Diarrhea Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Drugs for Traveler's Diarrhea Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Drugs for Traveler's Diarrhea Sales Value Share by Application (2021-2026) Table 41. Global Drugs for Traveler's Diarrhea Sales Value Share by Application (2027-2032) Table 42. Global Drugs for Traveler's Diarrhea Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Drugs for Traveler's Diarrhea Sales by Region (2021-2026) & (W Units) Table 44. Global Drugs for Traveler's Diarrhea Sales Market Share by Region (2021-2026) Table 45. Global Drugs for Traveler's Diarrhea Sales by Region (2027-2032) & (W Units) Table 46. Global Drugs for Traveler's Diarrhea Sales Market Share by Region (2027-2032) Table 47. Global Drugs for Traveler's Diarrhea Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Drugs for Traveler's Diarrhea Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Drugs for Traveler's Diarrhea Sales Value Share by Region (2021-2026) Table 50. Global Drugs for Traveler's Diarrhea Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Drugs for Traveler's Diarrhea Sales Value Share by Region (2027-2032) Table 52. Global Drugs for Traveler's Diarrhea Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Drugs for Traveler's Diarrhea Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Drugs for Traveler's Diarrhea Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Drugs for Traveler's Diarrhea Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Drugs for Traveler's Diarrhea Sales by Country (2021-2026) & (W Units) Table 57. Global Drugs for Traveler's Diarrhea Sales Market Share by Country (2021-2026) Table 58. Global Drugs for Traveler's Diarrhea Sales by Country (2027-2032) & (W Units) Table 59. Global Drugs for Traveler's Diarrhea Sales Market Share by Country (2027-2032) Table 60. Global Drugs for Traveler's Diarrhea Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Drugs for Traveler's Diarrhea Sales Value Market Share by Country (2021-2026) Table 62. Global Drugs for Traveler's Diarrhea Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Drugs for Traveler's Diarrhea Sales Value Market Share by Country (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GSK Drugs for Traveler's Diarrhea Product Portfolio Table 68. GSK Recent Development Table 69. Sigmoid Pharma Company Information Table 70. Sigmoid Pharma Business Overview Table 71. Sigmoid Pharma Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolio Table 73. Sigmoid Pharma Recent Development Table 74. Scandinavian Biopharma Company Information Table 75. Scandinavian Biopharma Business Overview Table 76. Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolio Table 78. Scandinavian Biopharma Recent Development Table 79. Salix Pharmaceuticals Company Information Table 80. Salix Pharmaceuticals Business Overview Table 81. Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio Table 83. Salix Pharmaceuticals Recent Development Table 84. Prokarium Limited Company Information Table 85. Prokarium Limited Business Overview Table 86. Prokarium Limited Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolio Table 88. Prokarium Limited Recent Development Table 89. Nippon Shinyaku Company Information Table 90. Nippon Shinyaku Business Overview Table 91. Nippon Shinyaku Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolio Table 93. Nippon Shinyaku Recent Development Table 94. Cosmo Pharmaceuticals Company Information Table 95. Cosmo Pharmaceuticals Business Overview Table 96. Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio Table 98. Cosmo Pharmaceuticals Recent Development Table 99. Chiesi Farmaceutici Company Information Table 100. Chiesi Farmaceutici Business Overview Table 101. Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolio Table 103. Chiesi Farmaceutici Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Drugs for Traveler's Diarrhea Distributors List Table 107. Drugs for Traveler's Diarrhea Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Drugs for Traveler's Diarrhea Product Image Figure 2. Global Drugs for Traveler's Diarrhea Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs for Traveler's Diarrhea Sales Value (2021-2032) & (US$ Million) Figure 4. Global Drugs for Traveler's Diarrhea Sales (2021-2032) & (W Units) Figure 5. Global Drugs for Traveler's Diarrhea Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Drugs for Traveler's Diarrhea Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antibiotics Image Figure 10. Anti-motility agents Image Figure 11. Bismuth Subsalicylate (Pepto-Bismol) Image Figure 12. Global Drugs for Traveler's Diarrhea Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Drugs for Traveler's Diarrhea Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Drugs for Traveler's Diarrhea Sales Volume Share by Type (2021-2032) Figure 15. Global Drugs for Traveler's Diarrhea Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Drugs for Traveler's Diarrhea Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Drugs for Traveler's Diarrhea Sales Value Share by Type (2021-2032) Figure 18. Adult Image Figure 19. Children Image Figure 20. Global Drugs for Traveler's Diarrhea Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Drugs for Traveler's Diarrhea Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Drugs for Traveler's Diarrhea Sales Volume Share by Application (2021-2032) Figure 23. Global Drugs for Traveler's Diarrhea Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Drugs for Traveler's Diarrhea Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Drugs for Traveler's Diarrhea Sales Value Share by Application (2021-2032) Figure 26. Global Drugs for Traveler's Diarrhea Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Drugs for Traveler's Diarrhea Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Drugs for Traveler's Diarrhea Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Drugs for Traveler's Diarrhea Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Drugs for Traveler's Diarrhea Sales Value (2021-2032) & (US$ Million) Figure 31. North America Drugs for Traveler's Diarrhea Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Drugs for Traveler's Diarrhea Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Drugs for Traveler's Diarrhea Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Drugs for Traveler's Diarrhea Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Drugs for Traveler's Diarrhea Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Drugs for Traveler's Diarrhea Sales Value (2021-2032) & (US$ Million) Figure 37. South America Drugs for Traveler's Diarrhea Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Drugs for Traveler's Diarrhea Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Drugs for Traveler's Diarrhea Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Drugs for Traveler's Diarrhea Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Drugs for Traveler's Diarrhea Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Anti-motility agents
  • Bismuth Subsalicylate (Pepto-Bismol)
Applications
  • Adult
  • Children
Companies covered
  • GSK
  • Sigmoid Pharma
  • Scandinavian Biopharma
  • Salix Pharmaceuticals
  • Prokarium Limited
  • Nippon Shinyaku
  • Cosmo Pharmaceuticals
  • Chiesi Farmaceutici

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drugs for Traveler's Diarrhea Sales Value (2021-2032)
  4. 1.2.2 Global Drugs for Traveler's Diarrhea Sales Volume (2021-2032)
  5. 1.2.3 Global Drugs for Traveler's Diarrhea Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Drugs for Traveler's Diarrhea Market Dynamics
  1. 2.1 Drugs for Traveler's Diarrhea Industry Trends
  2. 2.2 Drugs for Traveler's Diarrhea Industry Drivers
  3. 2.3 Drugs for Traveler's Diarrhea Industry Opportunities and Challenges
  4. 2.4 Drugs for Traveler's Diarrhea Industry Restraints
3 Drugs for Traveler's Diarrhea Market by Company
  1. 3.1 Global Drugs for Traveler's Diarrhea Company Revenue Ranking in 2025
  2. 3.2 Global Drugs for Traveler's Diarrhea Revenue by Company (2021-2026)
  3. 3.3 Global Drugs for Traveler's Diarrhea Sales Volume by Company (2021-2026)
  4. 3.4 Global Drugs for Traveler's Diarrhea Average Price by Company (2021-2026)
  5. 3.5 Global Drugs for Traveler's Diarrhea Company Ranking (2024-2026)
  6. 3.6 Global Drugs for Traveler's Diarrhea Company Manufacturing Base and Headquarters
  7. 3.7 Global Drugs for Traveler's Diarrhea Company Product Type and Application
  8. 3.8 Global Drugs for Traveler's Diarrhea Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Drugs for Traveler's Diarrhea Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Drugs for Traveler's Diarrhea Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Drugs for Traveler's Diarrhea Market by Type
  1. 4.1 Drugs for Traveler's Diarrhea Type Introduction
  2. 4.1.1 Antibiotics
  3. 4.1.2 Anti-motility agents
  4. 4.1.3 Bismuth Subsalicylate (Pepto-Bismol)
  5. 4.2 Global Drugs for Traveler's Diarrhea Sales Volume by Type
  6. 4.2.1 Global Drugs for Traveler's Diarrhea Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drugs for Traveler's Diarrhea Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Drugs for Traveler's Diarrhea Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Drugs for Traveler's Diarrhea Sales Value by Type
  10. 4.3.1 Global Drugs for Traveler's Diarrhea Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Drugs for Traveler's Diarrhea Sales Value by Type (2021-2032)
  12. 4.3.3 Global Drugs for Traveler's Diarrhea Sales Value Share by Type (2021-2032)
5 Drugs for Traveler's Diarrhea Market by Application
  1. 5.1 Drugs for Traveler's Diarrhea Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Drugs for Traveler's Diarrhea Sales Volume by Application
  5. 5.2.1 Global Drugs for Traveler's Diarrhea Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Drugs for Traveler's Diarrhea Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Drugs for Traveler's Diarrhea Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Drugs for Traveler's Diarrhea Sales Value by Application
  9. 5.3.1 Global Drugs for Traveler's Diarrhea Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Drugs for Traveler's Diarrhea Sales Value by Application (2021-2032)
  11. 5.3.3 Global Drugs for Traveler's Diarrhea Sales Value Share by Application (2021-2032)
6 Drugs for Traveler's Diarrhea Regional Sales and Value Analysis
  1. 6.1 Global Drugs for Traveler's Diarrhea Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drugs for Traveler's Diarrhea Sales by Region (2021-2032)
  3. 6.2.1 Global Drugs for Traveler's Diarrhea Sales by Region: 2021-2026
  4. 6.2.2 Global Drugs for Traveler's Diarrhea Sales by Region (2027-2032)
  5. 6.3 Global Drugs for Traveler's Diarrhea Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Drugs for Traveler's Diarrhea Sales Value by Region (2021-2032)
  7. 6.4.1 Global Drugs for Traveler's Diarrhea Sales Value by Region: 2021-2026
  8. 6.4.2 Global Drugs for Traveler's Diarrhea Sales Value by Region (2027-2032)
  9. 6.5 Global Drugs for Traveler's Diarrhea Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Drugs for Traveler's Diarrhea Sales Value (2021-2032)
  12. 6.6.2 North America Drugs for Traveler's Diarrhea Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Drugs for Traveler's Diarrhea Sales Value (2021-2032)
  15. 6.7.2 Europe Drugs for Traveler's Diarrhea Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Drugs for Traveler's Diarrhea Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Drugs for Traveler's Diarrhea Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Drugs for Traveler's Diarrhea Sales Value (2021-2032)
  21. 6.9.2 South America Drugs for Traveler's Diarrhea Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Drugs for Traveler's Diarrhea Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Drugs for Traveler's Diarrhea Sales Value Share by Country, 2025 VS 2032
7 Drugs for Traveler's Diarrhea Country-level Sales and Value Analysis
  1. 7.1 Global Drugs for Traveler's Diarrhea Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drugs for Traveler's Diarrhea Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Drugs for Traveler's Diarrhea Sales by Country (2021-2032)
  4. 7.3.1 Global Drugs for Traveler's Diarrhea Sales by Country (2021-2026)
  5. 7.3.2 Global Drugs for Traveler's Diarrhea Sales by Country (2027-2032)
  6. 7.4 Global Drugs for Traveler's Diarrhea Sales Value by Country (2021-2032)
  7. 7.4.1 Global Drugs for Traveler's Diarrhea Sales Value by Country (2021-2026)
  8. 7.4.2 Global Drugs for Traveler's Diarrhea Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Drugs for Traveler's Diarrhea Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Drugs for Traveler's Diarrhea Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Drugs for Traveler's Diarrhea Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Drugs for Traveler's Diarrhea Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Drugs for Traveler's Diarrhea Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Sigmoid Pharma
  8. 8.2.1 Sigmoid Pharma Company Information
  9. 8.2.2 Sigmoid Pharma Business Overview
  10. 8.2.3 Sigmoid Pharma Drugs for Traveler's Diarrhea Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolio
  12. 8.2.5 Sigmoid Pharma Recent Developments
  13. 8.3 Scandinavian Biopharma
  14. 8.3.1 Scandinavian Biopharma Company Information
  15. 8.3.2 Scandinavian Biopharma Business Overview
  16. 8.3.3 Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolio
  18. 8.3.5 Scandinavian Biopharma Recent Developments
  19. 8.4 Salix Pharmaceuticals
  20. 8.4.1 Salix Pharmaceuticals Company Information
  21. 8.4.2 Salix Pharmaceuticals Business Overview
  22. 8.4.3 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio
  24. 8.4.5 Salix Pharmaceuticals Recent Developments
  25. 8.5 Prokarium Limited
  26. 8.5.1 Prokarium Limited Company Information
  27. 8.5.2 Prokarium Limited Business Overview
  28. 8.5.3 Prokarium Limited Drugs for Traveler's Diarrhea Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolio
  30. 8.5.5 Prokarium Limited Recent Developments
  31. 8.6 Nippon Shinyaku
  32. 8.6.1 Nippon Shinyaku Company Information
  33. 8.6.2 Nippon Shinyaku Business Overview
  34. 8.6.3 Nippon Shinyaku Drugs for Traveler's Diarrhea Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolio
  36. 8.6.5 Nippon Shinyaku Recent Developments
  37. 8.7 Cosmo Pharmaceuticals
  38. 8.7.1 Cosmo Pharmaceuticals Company Information
  39. 8.7.2 Cosmo Pharmaceuticals Business Overview
  40. 8.7.3 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio
  42. 8.7.5 Cosmo Pharmaceuticals Recent Developments
  43. 8.8 Chiesi Farmaceutici
  44. 8.8.1 Chiesi Farmaceutici Company Information
  45. 8.8.2 Chiesi Farmaceutici Business Overview
  46. 8.8.3 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolio
  48. 8.8.5 Chiesi Farmaceutici Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drugs for Traveler's Diarrhea Value Chain Analysis
  2. 9.1.1 Drugs for Traveler's Diarrhea Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drugs for Traveler's Diarrhea Sales Mode & Process
  6. 9.2 Drugs for Traveler's Diarrhea Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drugs for Traveler's Diarrhea Distributors
  9. 9.2.3 Drugs for Traveler's Diarrhea Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst